Assesses immune cell behavior in dry eye disease, revealing patterns of stability and repeatability.
Objectives: To assess diurnal changes, topographical differences, and day-to-day repeatability of ocular surface epithelial immune cell (EIC) density and morphology in dry eye disease (DED). Methods: Sixteen participants with moderate-to-severe DED (mean (SE) age 49.4 (4.2) years) underwent in vivo confocal microscopy at three timepoints (day-1 morning and evening and day-2 morning) at six locations: central cornea, inferior whorl, inferior cornea, and temporal cornea, limbus and conjunctiva. Diurnal and topographical variation in EIC density and morphology were analyzed using linear mixed-effects models with adjusted pairwise comparisons. Day-to-day repeatability was assessed using the coefficient of repeatability (CoR) for density and Cohen’s kappa for morphology. Results: EIC density and morphology varied by location (p < 0.001) but not by timepoint at any location (p = 0.59–0.90). Density was highest at the inferior cornea (model-estimated mean: 101.2 (SE: 21.7) cells/mm2) and temporal limbus (104.3 (22.7) cells/mm2), and lowest at the central cornea (26.8 [5.1] cells/mm2 and inferior whorl (38.3 [8.2] cells/mm2; all pairwise, p < 0.001). EICs with large bodies were more frequent in conjunctiva (100%), inferior cornea (94%), and temporal cornea (87%), than in central cornea (34%) and whorl (19%) (all p ≤ 0.007). EICs with dendrites, and with long dendrites were similarly distributed (p < 0.001). Bland–Altman analysis showed low mean bias and EIC density was more repeatable at the central (CoR ± 23.8 cells/mm2) and temporal cornea (±27.5 cells/mm2) than the inferior cornea (±47.9 cells/mm2) or temporal conjunctiva (±42.3 cells/mm2). Morphology agreement was substantial to near-perfect (κ = 0.71–0.97). Conclusions: In DED, EIC density and morphology are diurnally stable and maintain topographic distribution patterns similar to healthy eyes. Day-to-day repeatability show location dependent patterns. The study provides feasibility data for using IVCM for EIC metrics in disease monitoring.
No takes yet. Share an insight, caveat, or question.
Sadhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: